A Magnetically Controlled Molecular Nanocontainer as a Drug Delivery System: The Effects of Carbon Nanotube and Magnetic Nanoparticle Parameters from Monte Carlo Simulations

被引:34
作者
Panczyk, Tomasz [1 ]
Warzocha, Tomasz P. [2 ]
Camp, Philip J. [3 ]
机构
[1] Polish Acad Sci, Inst Catalysis & Surface Chem, PL-30239 Krakow, Poland
[2] Marie Curie Sklodowska Univ, Dept Chem, PL-20031 Lublin, Poland
[3] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
关键词
BIOMEDICAL APPLICATIONS; TRANSPORTERS; DYNAMICS;
D O I
10.1021/jp1088405
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Monte Carlo simulations are used to study a carbon nanotube with a magnetic nanoparticle attached to each of its ends with a single -CH2- group. This system constitutes a switchable nanocontainer that can be used as a drug delivery system. The simulation force field comprises the magnetic dipole interactions (pairwise and with the external magnetic field) and the Hamaker potential for modeling the interactions of large nanoparticles. In the absence of an external magnetic field, the most favorable configurations are where the nanoparticles cap each end of the nanotube. Less favorable configurations occur when at least one of the nanoparticles detaches from the end of the nanotubc and is instead located in the vicinity of the sidewall; this is the uncapped state. It is shown that the capped and uncapped states differ in total energy and that the transition from one to the other is accompanied by an activation barrier. Analysis of the activation barriers and total energies leads to the conclusion that the capped state is preferred and that spontaneous uncapping should be insignificant. These characteristics are favored by large Hamaker constants, by large particle dimensions, and when the diameters of the nanotube and the nanoparticles are similar. The uncapping of the nanocontainer can be promoted by the interaction of ferromagnetic nanoparticles with an external magnetic field. The magnetic energy induced by the magnetic field may overcome the uncapping activation barriers provided that the nanoparticle diameters are large enough. It is shown that nanoparticles with diameters greater than 50 angstrom are effective as magnetically controlled caps operating under magnetic fields in the range 3-12 T; smaller nanoparticles would require much larger magnetic fields. The role of the mutual alignment of the magnetic moments associated with the nanoparticles is also discussed. In the case of larger nanoparticles (90 angstrom in diameter) the alignment of the magnetic moments is not critical; even with randomly assigned magnetic moments, a functional nanocontainer can be synthesized with a probability of around 75%.
引用
收藏
页码:21299 / 21308
页数:10
相关论文
共 32 条
[1]   Carbon nanohorns as anticancer drug carriers [J].
Ajima, Kumiko ;
Yudasaka, Masako ;
Murakami, Tatsuya ;
Maigne, Alan ;
Shiba, Kiyotaka ;
Ijima, Sumio .
MOLECULAR PHARMACEUTICS, 2005, 2 (06) :475-480
[2]  
Alexiou C, 2000, CANCER RES, V60, P6641
[3]   Separation of fine mineral particles by selective magnetic coating [J].
Anastassakis, GN .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2002, 256 (01) :114-120
[4]   Magnetic nanoparticles for drug delivery [J].
Arruebo, Manuel ;
Fernandez-Pacheco, Rodrigo ;
Ibarra, M. Ricardo ;
Santamaria, Jesus .
NANO TODAY, 2007, 2 (03) :22-32
[5]   Biomedical applications of functionalised carbon nanotubes [J].
Bianco, A ;
Kostarelos, K ;
Partidos, CD ;
Prato, M .
CHEMICAL COMMUNICATIONS, 2005, (05) :571-577
[6]   Nanotechnology: Intelligent design to treat complex disease [J].
Couvreur, Patrick ;
Vauthier, Christine .
PHARMACEUTICAL RESEARCH, 2006, 23 (07) :1417-1450
[7]   Interaction potentials for soft and hard ellipsoids [J].
Everaers, R ;
Ejtehadi, MR .
PHYSICAL REVIEW E, 2003, 67 (04) :8
[8]  
Hansen MF, 1998, J MAGN MAGN MATER, V184, P262, DOI 10.1016/S0304-8853(97)01165-7
[9]   Modeling the Loading and Unloading of Drugs into Nanotubes [J].
Hilder, Tamsyn A. ;
Hill, James M. .
SMALL, 2009, 5 (03) :300-308
[10]   Folate receptor-mediated drug targeting: From therapeutics to diagnostics [J].
Hilgenbrink, AR ;
Low, PS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (10) :2135-2146